3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 24 0 1 0 0 0 0 0999 V2000
2.9639 0.5026 -0.0818 P 0 0 0 0 0 0 0 0 0 0 0 0
3.8600 1.6620 0.5835 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9462 0.8731 -1.6479 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5820 -2.1613 -0.8272 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3367 -0.8962 0.2599 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3548 -1.7611 1.3939 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7125 -0.1997 -0.7120 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8916 1.3403 0.7518 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1791 0.1024 -0.1693 C 0 0 2 0 0 0 0 0 0 0 0 0
1.2928 0.9549 0.4427 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2120 0.6235 0.2388 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3679 -0.1265 -0.4255 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3825 -1.3477 0.2422 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7140 0.4336 -0.0491 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2654 0.1611 -1.2618 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2635 0.8896 1.5370 H 0 0 0 0 0 0 0 0 0 0 0 0
1.1367 2.0078 0.1798 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3234 0.5588 1.3293 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.2845 1.6890 -0.0157 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3525 -1.1812 -0.1308 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2651 -0.0609 -1.5145 H 0 0 0 0 0 0 0 0 0 0 0 0
4.8340 1.6382 0.4702 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7444 0.6973 -2.1901 H 0 0 0 0 0 0 0 0 0 0 0 0
0.7033 -3.0966 -0.5570 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.5947 0.1567 -0.4731 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0 0 0 0
1 3 1 0 0 0 0
1 5 2 0 0 0 0
1 10 1 0 0 0 0
2 22 1 0 0 0 0
3 23 1 0 0 0 0
4 13 1 0 0 0 0
4 24 1 0 0 0 0
6 13 2 0 0 0 0
7 14 1 0 0 0 0
7 25 1 0 0 0 0
8 14 2 0 0 0 0
9 10 1 0 0 0 0
9 11 1 0 0 0 0
9 13 1 0 0 0 0
9 15 1 0 0 0 0
10 16 1 0 0 0 0
10 17 1 0 0 0 0
11 12 1 0 0 0 0
11 18 1 0 0 0 0
11 19 1 0 0 0 0
12 14 1 0 0 0 0
12 20 1 0 0 0 0
12 21 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-(phosphonomethyl)pentanedioic acid
4.2 InChl
InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13)
4.3 InChlKey
ISEYJGQFXSTPMQ-UHFFFAOYSA-N
4.4 Canonical SMILES
C(CC(=O)O)C(CP(=O)(O)O)C(=O)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病